Anti-CD19 CAR / NFAT (Luciferase) Reporter Jurkat Cell Line (CD19 SCFV-CD28-4-1BB-CD3?)
Product Code
79853
$0.00
Order Support
-
Email: [email protected]
Order Support
- Email: [email protected]
Order Support
- Email: [email protected]
Order Support
-
T: +1 (800) 987 0985 (toll free)
-
Email: [email protected]
Order Support
-
Email: [email protected]
Shipping Information
-
Delivery charges will be calculated during checkout
Product Updates
-
Keep up to date with product offers, resources and news
Anti-CD19 CAR/NFAT-luciferase reporter Jurkat cell line is a double stable cell line expressing anti-CD19 CAR and NFAT-luciferase reporter. It is made from the anti-CD19 CAR lentivirus ( #79851). The reporter cell line has been validated for anti CD19-CAR expression by FACS/ and for luciferase reporter activation stimulated by target cells including CD19/CHO recombinant cell line can be used for primary screening and functional validation of anti-CD19 CAR construct and lentivirus before testing in primary T cells.
Anti-CD19 CAR consists of anti-CD19 scFv linked to 3rd generation CAR (Chimeric Antigen Receptor) containing CD28/ 4-1BB co-stimulatory domains/ and CD3? signaling domain.
Anti-CD19 CAR consists of anti-CD19 scFv linked to 3rd generation CAR (Chimeric Antigen Receptor) containing CD28/ 4-1BB co-stimulatory domains/ and CD3? signaling domain.
SKU | 79853 |
---|---|
Size | 2 vials |
Alternate SKU | AMS.79853 |
Application | • Validate different CAR designs and constructs for their specificity/ efficacy and potency before proceeding into patient-derived primary T cells. • Predict the Mechanism of Action (MOA) of CAR. • Intracellular co-stimulatory and activ |
Storage | Immediately upon receipt/ store in liquid nitrogen. |
Shipping Temp | -80C (dry ice) |
Supplier Name | BPS |